Infectious disease causes 35 percent of deaths worldwide, and is the world’s biggest killer of children and young adults. Our researchers are focused on basic bacterial and viral infectious disease processes and the design and use of vaccines and protein therapeutics to combat infectious diseases. These include newly-emerging pathogens and potential biowarfare agents. We are devising new and effective ways of producing advanced vaccines and therapeutics, such as through the use of recombinant attenuated bacteria and viruses and genetically modified plants, and transferring this technology to the developing world to help fight diseases. Read More »